cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Accolade Inc
11 own
14 watching
Current Price
$11.28
$0.67
(6.31%)
logo-accd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
816.57M
52-Week High
52-Week High
22.92
52-Week Low
52-Week Low
4.61
Average Volume
Average Volume
0.56M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization816.57M
icon52-Week High22.92
icon52-Week Low4.61
iconAverage Volume0.56M
iconDividend Yield--
iconP/E Ratio--
What does the Accolade Inc do?
Our innovative platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians (including nurses, physician medical directors, and behavioral health specialists). We leverage our integrated capabilities, connectivity with providers and the broader healthcare ecosystem, and longitudinal data to engage across the entire member population, rather than focusing solely on high-cost claimants or those with chronic conditions. We were formed under the laws of the state of Delaware in January 2007 under the name Accretive Care LLC, and we converted to a Delaware corporation under the name Accolade, Inc. in June 2010. Our principal executive offices are located at 1201 Third Avenue, Suite 1700, Seattle, WA 98101, and we have co-headquarters at 660 West Germantown Pike, Suite 500, Plymouth Meeting, PA 19462. Our telephone number is (206) 926-8100. Our website address is www.accolade.com.
Read More
How much money does Accolade Inc make?
News & Events about Accolade Inc.
Globe Newswire
24days ago
SEATTLE, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will participate in the 25th Annual Needham Growth Conference on Wednesday, January 11, 2023 and will host a fireside chat at 1:30 pm ET. A webcast and replay of the fireside chat will be available at ir...
Ticker Report
25days ago
Accolade, Inc. (NASDAQ:ACCD Get Rating) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 3,280,000 shares, a decline of 17.2% from the November 30th total of 3,960,000 shares. Based on an average daily trading volume, of 646,200...
Globe Newswire
1month ago
SEATTLE, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members,today announced that it will release fiscal third quarter 2023 financial results on Monday, January 9, 2023, after the market closes. In conjunction, the company will host ...
PR Newswire
2 months ago
Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022 Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022 PR Newswire SEATTLE, Nov. 14, 2022 Chief Medical Officer Dr. Shantanu Nundy and Dr. Jay Bhatt...
PR Newswire
5 months ago
Carrum Health Selected as Trusted Partner by Accolade to Help Employers Achieve Immediate and Tangible Cost Savings Carrum Health Selected as Trusted Partner by Accolade to Help Employers Achieve Immediate and Tangible Cost Savings PR Newswire SAN FRANCISCO, Aug. 17, 2022 Carrum's Value-Based...
Frequently Asked Questions
Frequently Asked Questions
What is Accolade Inc share price today?
plus_minus_icon
Can Indians buy Accolade Inc shares?
plus_minus_icon
How can I buy Accolade Inc shares from India?
plus_minus_icon
Can Fractional shares of Accolade Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Accolade Inc stocks?
plus_minus_icon
What is today’s traded volume of Accolade Inc?
plus_minus_icon
What is today’s market capitalisation of Accolade Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Accolade Inc?
plus_minus_icon
What percentage is Accolade Inc down from its 52-Week High?
plus_minus_icon
What percentage is Accolade Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.28
$0.67
(6.31%)
logo-accd
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PULMONX CORP
PULMONX CORP
$9.20
$0.25 (2.79 %)
Valneva SE
Valneva SE
$14.03
$0.29 (2.11 %)
Zomedica Corp
Zomedica Corp
$0.26
$0.01 (3.12 %)
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
$66.02
$-1.37 (-2.03 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
PULMONX CORP
PULMONX CORP
$9.20
$0.25 (2.79 %)
Valneva SE
Valneva SE
$14.03
$0.29 (2.11 %)
Zomedica Corp
Zomedica Corp
$0.26
$0.01 (3.12 %)
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc
$66.02
$-1.37 (-2.03 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00